Don E Eslin MD

Pediatric Hematology & Oncology•Tampa, FL

Physician

Join to View Full Profile

3001 W Dr Martin Luther King Jr BlvdTampa, FL 33607
Phone+1 813-321-6820
Fax+1 813-287-6306

Education & Training

Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2000 - 2003
University of Florida (Orlando)Residency, Pediatrics, 1997 - 2000
Marshall University Joan C. Edwards School of MedicineClass of 1997

Certifications & Licensure

FL State Medical License 2000 - 2027
PA State Medical License 2000 - 2004
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer Start of enrollment: 2007 May 01
Completed
Phase 3
Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma Start of enrollment: 2008 Jan 14
COMPLETED
PHASE2
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Start of enrollment: 2010 Jun 01
Terminated
Phase 3
Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) Start of enrollment: 2011 Jul 18
Completed
Phase 1
Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma
TERMINATED
PHASE1, PHASE2
Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma
TERMINATED
PHASE1, PHASE2
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission Start of enrollment: 2012 Jun 01
Active, not recruiting
Phase 2
Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer Start of enrollment: 2013 Mar 04
COMPLETED
NA
Study of Difluoromethylornithine (DFMO) in Combination With Bortezomib for Relapsed or Refractory Neuroblastoma Start of enrollment: 2014 Jun 06
COMPLETED
PHASE1, PHASE2
Molecular-Guided Therapy for Childhood Cancer Start of enrollment: 2014 Jul 08
COMPLETED
NA
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
RECRUITING
PHASE2
Neuroblastoma Maintenance Therapy Trial
RECRUITING
PHASE2
Join now to see all

Publications & Presentations

PubMed

1 citations
A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma.
Don Eslin, Peter E Zage, Genevieve Bergendahl, Elizabeth Lewis, William Roberts
International Journal of Cancer. 2023-09-01
11 citations
Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion
Sara A. Byron, William P.D. Hendricks, Abhinav Nagulapally, Jacqueline M. Kraveka, William S. Ferguson
Cancer Research. 2021-10-05
41 citations
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma
Elizabeth C. Lewis, Jacqueline M. Kraveka, William S. Ferguson, Don Eslin, Valerie I. Brown
International Journal of Cancer. 2020-12-01

Lectures

29th Annual Colin J. Condron Care of the Sick Child Conference
Orlando Health, Orlando, Florida - 11/7/2012

Press Mentions

‘Forced to Retract Completely into Ourselves,’ a Mother and Son Confront Cancer in the Age of Covid-19May 27th, 2020

Professional Memberships

American Academy of Pediatrics - AAP
Fellow